This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
EX1 | Ann: Explainer The critical bottleneck of exosome isolation | 20:38 | 2 | 363 | |||
|
|||||||
EX1 | People offloading | 07:13 | 1 | 239 | |||
|
|||||||
EX1 | Pull back | 11/03/19 | 2 | 1.1K | |||
|
|||||||
EX1 | Ann: Appendix 4D and Interim Financial Report - Dec 18 Half Year | 07/03/19 | 1 | 695 | |||
|
|||||||
EX1 | Ann: Positive outcomes in first animal study involving Plexaris | 07/02/19 | 8 | 2.4K | |||
|
|||||||
EX1 | Ann: December 2018 Quarterly Activities Report | 06/02/19 | 6 | 1.3K | |||
|
|||||||
EX1 | Animal Studies | 04/02/19 | 0 | 428 | |||
|
|||||||
EX1 | Ann: December 2018 Quarterly Cash Flow Report | 01/02/19 | 6 | 1.8K | |||
|
See All Discussions